
### [NCIT:C26865](http://purl.obolibrary.org/obo/NCIT_C26865)
**Label:** Prostate Disorder

**Subclasses:** [NCIT:C6813](http://purl.obolibrary.org/obo/NCIT_C6813) (Prostate Ductal Adenocarcinoma), [NCIT:C7902](http://purl.obolibrary.org/obo/NCIT_C7902) (Recurrent Prostate Carcinoma), [NCIT:C5525](http://purl.obolibrary.org/obo/NCIT_C5525) (Prostate Embryonal Rhabdomyosarcoma), [NCIT:C5526](http://purl.obolibrary.org/obo/NCIT_C5526) (Prostate Leiomyosarcoma), [NCIT:C5527](http://purl.obolibrary.org/obo/NCIT_C5527) (Prostate Myeloid Sarcoma), [NCIT:C3343](http://purl.obolibrary.org/obo/NCIT_C3343) (Prostate Neoplasm), [NCIT:C5528](http://purl.obolibrary.org/obo/NCIT_C5528) (Prostate Angiosarcoma), [NCIT:C4795](http://purl.obolibrary.org/obo/NCIT_C4795) (Prostate Adenoma), [NCIT:C5522](http://purl.obolibrary.org/obo/NCIT_C5522) (Prostate Rhabdomyosarcoma), [NCIT:C5523](http://purl.obolibrary.org/obo/NCIT_C5523) (Prostate Kaposi Sarcoma), [NCIT:C5524](http://purl.obolibrary.org/obo/NCIT_C5524) (Prostate Stromal Sarcoma), [NCIT:C48596](http://purl.obolibrary.org/obo/NCIT_C48596) (Invasive Prostate Carcinoma), [NCIT:C103817](http://purl.obolibrary.org/obo/NCIT_C103817) (Hereditary Prostate Carcinoma), [NCIT:C5536](http://purl.obolibrary.org/obo/NCIT_C5536) (Prostate Squamous Cell Carcinoma), [NCIT:C132881](http://purl.obolibrary.org/obo/NCIT_C132881) (Metastatic Prostate Carcinoma in the Soft Tissue), [NCIT:C5538](http://purl.obolibrary.org/obo/NCIT_C5538) (Prostate Adenosquamous Carcinoma), [NCIT:C5539](http://purl.obolibrary.org/obo/NCIT_C5539) (Prostate Adenoid Cystic Carcinoma), [NCIT:C5532](http://purl.obolibrary.org/obo/NCIT_C5532) (Benign Prostate Phyllodes Tumor), [NCIT:C5533](http://purl.obolibrary.org/obo/NCIT_C5533) (Prostate Lymphoma), [NCIT:C5534](http://purl.obolibrary.org/obo/NCIT_C5534) (Prostate Non-Hodgkin Lymphoma), [NCIT:C5531](http://purl.obolibrary.org/obo/NCIT_C5531) (Malignant Prostate Phyllodes Tumor), [NCIT:C7080](http://purl.obolibrary.org/obo/NCIT_C7080) (Metastatic Malignant Neoplasm in the Prostate Gland), [NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation), [NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma), [NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential), [NCIT:C39904](http://purl.obolibrary.org/obo/NCIT_C39904) (Tumor of Specialized Prostatic Stroma), [NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma), [NCIT:C5544](http://purl.obolibrary.org/obo/NCIT_C5544) (Prostate Leiomyoma), [NCIT:C5545](http://purl.obolibrary.org/obo/NCIT_C5545) (Prostate Neuroendocrine Neoplasm), [NCIT:C5024](http://purl.obolibrary.org/obo/NCIT_C5024) (Prostate Carcinoid Tumor), [NCIT:C26865](http://purl.obolibrary.org/obo/NCIT_C26865) (Prostate Disorder), [NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern), [NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern), [NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern), [NCIT:C2919](http://purl.obolibrary.org/obo/NCIT_C2919) (Prostate Adenocarcinoma), [NCIT:C27916](http://purl.obolibrary.org/obo/NCIT_C27916) (Poorly Differentiated Prostate Adenocarcinoma), [NCIT:C36308](http://purl.obolibrary.org/obo/NCIT_C36308) (Prostate Carcinoma Metastatic in the Bone), [NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma), [NCIT:C36307](http://purl.obolibrary.org/obo/NCIT_C36307) (Prostate Carcinoma Metastatic in the Lung), [NCIT:C39898](http://purl.obolibrary.org/obo/NCIT_C39898) (Primary Prostate Urothelial Carcinoma), [NCIT:C8946](http://purl.obolibrary.org/obo/NCIT_C8946) (Metastatic Prostate Carcinoma), [NCIT:C8945](http://purl.obolibrary.org/obo/NCIT_C8945) (Metastatic Prostatic Adenocarcinoma), [NCIT:C3613](http://purl.obolibrary.org/obo/NCIT_C3613) (Benign Prostate Neoplasm), [NCIT:C4863](http://purl.obolibrary.org/obo/NCIT_C4863) (Prostate Carcinoma), [NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma), [NCIT:C6766](http://purl.obolibrary.org/obo/NCIT_C6766) (Prostate Small Cell Carcinoma), [NCIT:C7574](http://purl.obolibrary.org/obo/NCIT_C7574) (Prostate Phyllodes Tumor), [NCIT:C7731](http://purl.obolibrary.org/obo/NCIT_C7731) (Prostate Sarcoma), [NCIT:C5596](http://purl.obolibrary.org/obo/NCIT_C5596) (Prostate Acinar Adenocarcinoma), [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm), [NCIT:C5597](http://purl.obolibrary.org/obo/NCIT_C5597) (Prostate Undifferentiated Carcinoma), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C37268](http://purl.obolibrary.org/obo/NCIT_C37268) (Atypical Small Acinar Proliferation of the Prostate Gland), [NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant), [NCIT:C27905](http://purl.obolibrary.org/obo/NCIT_C27905) (Well Differentiated Prostate Adenocarcinoma), [NCIT:C27906](http://purl.obolibrary.org/obo/NCIT_C27906) (Moderately Differentiated Prostate Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C26865](http://purl.obolibrary.org/obo/NCIT_C26865) (Prostate Disorder) 99.12%
- [NCIT:C3343](http://purl.obolibrary.org/obo/NCIT_C3343) (Prostate Neoplasm) 98.25%
- [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) 87.72%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) and [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) 82.46%
- [NCIT:C27019](http://purl.obolibrary.org/obo/NCIT_C27019) (Male Reproductive System Disorder) 80.41%
- [NCIT:C3054](http://purl.obolibrary.org/obo/NCIT_C3054) (Male Reproductive System Neoplasm) 80.28%
- [NCIT:C4863](http://purl.obolibrary.org/obo/NCIT_C4863) (Prostate Carcinoma) 75.44%
- [NCIT:C7062](http://purl.obolibrary.org/obo/NCIT_C7062) (Neoplasm by Special Category) and [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) 75.44%
- [NCIT:C3709](http://purl.obolibrary.org/obo/NCIT_C3709) (Epithelial Neoplasm) and [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) 75.44%
- [NCIT:C2916](http://purl.obolibrary.org/obo/NCIT_C2916) (Carcinoma) and [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) 75.44%
- [NCIT:C7378](http://purl.obolibrary.org/obo/NCIT_C7378) (Malignant Prostate Neoplasm) and [NCIT:C9305](http://purl.obolibrary.org/obo/NCIT_C9305) (Malignant Neoplasm) 72.81%
- [NCIT:C3343](http://purl.obolibrary.org/obo/NCIT_C3343) (Prostate Neoplasm) and [NCIT:C8561](http://purl.obolibrary.org/obo/NCIT_C8561) (Malignant Male Reproductive System Neoplasm) and [NCIT:C9305](http://purl.obolibrary.org/obo/NCIT_C9305) (Malignant Neoplasm) 72.81%
- [NCIT:C26865](http://purl.obolibrary.org/obo/NCIT_C26865) (Prostate Disorder) and [NCIT:C8561](http://purl.obolibrary.org/obo/NCIT_C8561) (Malignant Male Reproductive System Neoplasm) and [NCIT:C9305](http://purl.obolibrary.org/obo/NCIT_C9305) (Malignant Neoplasm) 72.81%
- [NCIT:C8561](http://purl.obolibrary.org/obo/NCIT_C8561) (Malignant Male Reproductive System Neoplasm) 71.36%
- [NCIT:C4863](http://purl.obolibrary.org/obo/NCIT_C4863) (Prostate Carcinoma) and [NCIT:C9305](http://purl.obolibrary.org/obo/NCIT_C9305) (Malignant Neoplasm) 71.05%


